Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus

Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus

(2022) Victoria P. Werth et al.   NEW ENGLAND JOURNAL OF MEDICINE

Evaluating Change in Disease Activity Needed to Reflect Meaningful Improvement in Quality of Life for Clinical Trials in Cutaneous Lupus Erythematosus

(2020) Srita Chakka et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus

(2019) Richard Furie et al.   JOURNAL OF CLINICAL INVESTIGATION

Novel paradigms in systemic lupus erythematosus

(2019) Thomas Dörner et al.   LANCET

2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus

(2019) Martin Aringer et al.   ANNALS OF THE RHEUMATIC DISEASES

Trial of Anifrolumab in Active Systemic Lupus Erythematosus

(2019) Eric F. Morand et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical trial parameters that influence outcomes in lupus trials that use the systemic lupus erythematosus responder index

(2017) Kenneth C Kalunian et al.   RHEUMATOLOGY

Anti-BDCA2 monoclonal antibody inhibits plasmacytoid dendritic cell activation through Fc-dependent and Fc-independent mechanisms

(2015) A. Pellerin et al.   EMBO Molecular Medicine

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

(2011) Richard Furie et al.   ARTHRITIS AND RHEUMATISM

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

(2011) Sandra V Navarra et al.   LANCET

Type I interferons: diversity of sources, production pathways and effects on immune responses

(2011) Melissa Swiecki et al.   Current Opinion in Virology

Plasmacytoid dendritic cells: an overview of their presence and distribution in different inflammatory skin diseases, with special emphasis on Jessner's lymphocytic infiltrate of the skin and cutaneous lupus erythematosus

(2010) Dario Tomasini et al.   JOURNAL OF CUTANEOUS PATHOLOGY

Plasmacytoid Dendritic Cells

(2009) Armin G. Jegalian et al.   ADVANCES IN ANATOMIC PATHOLOGY

Novel evidence-based systemic lupus erythematosus responder index

(2009) Richard A. Furie et al.   ARTHRITIS AND RHEUMATISM

The innate immune system in SLE: type I interferons and dendritic cells

(2008) L Rönnblom et al.   LUPUS